-
Symbol
-
TNGX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
8.54M shares
-
Security Ownership
-
6.3%
TCG Crossover GP II, LLC ownership in Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX)
2025-11-14 - TCG Crossover GP II, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.54M shares of Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX).
This represents 6.3% percent ownership of the company.